Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""PARKINSONIAN disorders"" wg kryterium: Temat


Tytuł:
Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP.
Autorzy:
Oláh J; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary.
Norris V; Laboratory of Bacterial Communication and Anti-Infection Strategies, EA 4312, University of Rouen, 76821 Mont Saint Aignan, France.
Lehotzky A; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary.
Ovádi J; Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, H-1117 Budapest, Hungary.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 14; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Parkinsonian Disorders*/therapy
Parkinsonian Disorders*/metabolism
Parkinson Disease*/metabolism
Humans ; Microtubules/metabolism ; Peptide Hydrolases/metabolism ; Proteolysis
Czasopismo naukowe
Tytuł:
Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.
Autorzy:
Essawy Essawy A; Department of Zoology, Faculty of Science, Alexandria University, Alexandria, Egypt.
Abou-ElNaga OA; Department of Zoology, Faculty of Science, Alexandria University, Alexandria, Egypt.
Mehanna RA; Department of Physiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Badae NM; Department of Physiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Elsawy ES; Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Soffar AA; Department of Zoology, Faculty of Science, Alexandria University, Alexandria, Egypt.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 13; Vol. 19 (2), pp. e0296297. Date of Electronic Publication: 2024 Feb 13 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Parkinsonian Disorders*/therapy
Parkinsonian Disorders*/drug therapy
Parkinson Disease*/metabolism
Mesenchymal Stem Cells*/metabolism
Humans ; Rats ; Male ; Animals ; alpha-Synuclein/metabolism ; Substantia Nigra/metabolism ; Rotenone/pharmacology ; Dopa Decarboxylase/metabolism ; Administration, Intravenous ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
Hypoxia Sensing and Responses in Parkinson's Disease.
Autorzy:
Burtscher J; Institute of Sport Sciences, University of Lausanne, 1015 Lausanne, Switzerland.
Duderstadt Y; Division of Cardiology and Angiology, University Hospital Magdeburg, 39120 Magdeburg, Germany.; Research Group Neuroprotection, German Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany.; Department of Sports Science, Otto-von-Guericke University, 39120 Magdeburg, Germany.
Gatterer H; Institute of Mountain Emergency Medicine, Eurac Research, 39100 Bolzano, Italy.
Burtscher M; Department of Sport Science, University of Innsbruck, 6020 Innsbruck, Austria.
Vozdek R; Institute for Biomedicine, Eurac Research, Via Alessandro Volta 21, 39100 Bolzano, Italy.
Millet GP; Institute of Sport Sciences, University of Lausanne, 1015 Lausanne, Switzerland.
Hicks AA; Institute for Biomedicine, Eurac Research, Via Alessandro Volta 21, 39100 Bolzano, Italy.
Ehrenreich H; Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, 37075 Goettingen, Germany.; Experimental Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
Kopp M; Department of Sport Science, University of Innsbruck, 6020 Innsbruck, Austria.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 01; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Parkinson Disease*/pathology
Parkinsonian Disorders*/pathology
Humans ; alpha-Synuclein ; Dopaminergic Neurons/pathology ; Hypoxia/pathology ; Oxygen
Czasopismo naukowe
Tytuł:
Beyond traditional training: Integrating data from semi-immersive VR dual-task intervention in Parkinsonian Syndromes. A study protocol.
Autorzy:
Bruni F; Faculty of Psychology, eCampus University, Novedrate, Italy.
Mancuso V; Faculty of Psychology, eCampus University, Novedrate, Italy.
Stramba-Badiale C; Applied Technology for Neuropsychology Lab, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Stramba-Badiale M; Department of Geriatrics and Cardiovascular Medicine, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Riva G; Applied Technology for Neuropsychology Lab, IRCCS Istituto Auxologico Italiano, Milan, Italy.; Human Technology Lab, Catholic University of the Sacred Heart, Milan, Italy.
Goulene K; Department of Geriatrics and Cardiovascular Medicine, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Cipresso P; Department of Psychology, University of Turin, Turin, Italy.; Istituto Auxologico Italiano, IRCCS, Unit of Neurology and Neurorehabilitation, San Giuseppe Hospital Piancavallo, Verbania, Italy.
Pedroli E; Faculty of Psychology, eCampus University, Novedrate, Italy.; Department of Geriatrics and Cardiovascular Medicine, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 01; Vol. 19 (2), pp. e0294199. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Parkinsonian Disorders*
Virtual Reality*
Humans ; Reproducibility of Results ; Walking ; Gait
Czasopismo naukowe
Tytuł:
Distinct forebrain regions define a dichotomous astrocytic profile in multiple system atrophy.
Autorzy:
Schneider Y; Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Gauer C; Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Andert M; Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Hoffmann A; Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.; UK Dementia Research Institute, The University of Edinburgh, Edinburgh, UK.; Keenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, ON, Canada.; Department of Immunology, The University of Toronto, Toronto, ON, Canada.
Riemenschneider MJ; Department of Neuropathology, Regensburg University Hospital, 93053, Regensburg, Germany.
Krebs W; Core Unit Bioinformatics, Data Integration and Analysis (CUBiDA), University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
Chalmers N; Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.
Lötzsch C; Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.
Naumann UJ; Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.
Xiang W; Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.
Rothhammer V; Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.
Beckervordersandforth R; Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, 91054, Erlangen, Germany.
Schlachetzki JCM; Department of Cellular and Molecular Medicine, University of California-San Diego, La Jolla, CA, 92093, USA.
Winkler J; Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Jan 02; Vol. 12 (1), pp. 1. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple System Atrophy*/pathology
Parkinsonian Disorders*/pathology
Humans ; Mice ; Animals ; Astrocytes/metabolism ; Corpus Striatum/metabolism ; Substantia Nigra/metabolism ; Mice, Transgenic
Czasopismo naukowe
Tytuł:
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan.
Autorzy:
Ando M; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Higuchi Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Yuan J; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Yoshimura A; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Kojima F; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Yamanishi Y; Department of Neurology and Clinical Pharmacology, Ehime University Hospital, Toon, Ehime, Japan.
Aso Y; Department of Neurology, Oita Prefecture Hospital, Oita, Japan.
Izumi K; Department of Neurology, Ohashi Go Neurosurgical Neurology Clinic, Fukuoka, Japan.
Imada M; Department of Neurology, National Hospital Organization Minamikyushu Hospital, Kagoshima, Japan.
Maki Y; Department of Neurology, Kagoshima City Hospital, Kagoshima, Japan.
Nakagawa H; Department of Neurology, Kagoshima Medical Association Hospital, Kagoshima, Japan.
Hobara T; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Noguchi Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Takei J; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Hiramatsu Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Nozuma S; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Sakiyama Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Hashiguchi A; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Matsuura E; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Okamoto Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.; Department of Physical Therapy, Faculty of Medicine, School of Health Sciences, Kagoshima University, Kagoshima, Japan.
Takashima H; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Jan; Vol. 11 (1), pp. 96-104. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cerebellar Ataxia*/genetics
Friedreich Ataxia*/genetics
Spinocerebellar Degenerations*/genetics
Parkinsonian Disorders*
Fibroblast Growth Factors*
Humans ; Middle Aged ; Aged ; Follow-Up Studies ; Japan ; Atrophy
Czasopismo naukowe
Tytuł:
Infantile-onset parkinsonism, dyskinesia, and developmental delay: do not forget polyglutamine defects!
Autorzy:
Baide-Mairena H; Département de Neuropédiatrie, Hôpital Gui de Chauliac, Montpellier, France.; Universitat Autònoma de Barcelona, Barcelona, Spain.
Coget A; Service de Neuroradiologie, Hôpital Gui de Chauliac, Montpellier, France.
Leboucq N; Service de Neuroradiologie, Hôpital Gui de Chauliac, Montpellier, France.
Procaccio V; MitoLab, UMR CNRS 6015 - INSERM U1083, MitoVasc Institute, Angers University Hospital, Angers, France.
Blanluet M; MitoLab, UMR CNRS 6015 - INSERM U1083, MitoVasc Institute, Angers University Hospital, Angers, France.
Meyer P; Département de Neuropédiatrie, Hôpital Gui de Chauliac, Montpellier, France.; Phymedexp, Montpellier University, Inserm, CNRS, Montpellier, France.
Malinge MC; MitoLab, UMR CNRS 6015 - INSERM U1083, MitoVasc Institute, Angers University Hospital, Angers, France.
François-Heude MC; Département de Neuropédiatrie, Hôpital Gui de Chauliac, Montpellier, France.
Moreno M; Département de Neuropédiatrie, Hôpital Gui de Chauliac, Montpellier, France.
Geneviève D; Montpellier University, Inserm U1183, Montpellier, France.; Reference Center for Malformative Syndrome, Genetic Department, Montpellier Hospital, Montpellier, France.
Marelli C; Expert Centre for Neurogenetic Diseases and Adult Mitochondrial and Metabolic Diseases, Department of Neurology, Montpellier University Hospital, Montpellier, France.; MMDN, University of Montpellier, EPHE, INSERM, Montpellier, France.
Roubertie A; Département de Neuropédiatrie, Hôpital Gui de Chauliac, Montpellier, France.; Institut des Neurosciences de Montpellier, INSERM U 1298, Montpellier, France.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Oct; Vol. 10 (10), pp. 1937-1943. Date of Electronic Publication: 2023 Jul 25.
Typ publikacji:
Case Reports
MeSH Terms:
Brain Diseases*/genetics
Dyskinesias*
Parkinsonian Disorders*/diagnosis
Parkinsonian Disorders*/genetics
Male ; Infant ; Humans ; Peptides
Raport
Tytuł:
Evaluating the ability of a predictive vision-based machine learning model to measure changes in gait in response to medication and DBS within individuals with Parkinson's disease.
Autorzy:
Sabo A; KITE, Toronto Rehabilitation Institute, University Health Network, 550 University Avenue, Toronto, ON, M5G 2A2, Canada.
Iaboni A; KITE, Toronto Rehabilitation Institute, University Health Network, 550 University Avenue, Toronto, ON, M5G 2A2, Canada.; Department of Psychiatry, University of Toronto, 250 College Street, 8th Floor, Toronto, ON, M5T 1R8, Canada.; Centre for Mental Health, University Health Network, 33 Russell Street, Toronto, ON, M5S 2S1, Canada.
Taati B; KITE, Toronto Rehabilitation Institute, University Health Network, 550 University Avenue, Toronto, ON, M5G 2A2, Canada.; Department of Computer Science, University of Toronto, 10 King's College Road, Room 3302, Toronto, ON, M5S 3G4, Canada.; Institute of Biomedical Engineering, University of Toronto, 164 College Street. Room 407, Toronto, ON, M2S 3G9, Canada.; Vector Institute, 661 University Ave Suite 710, Toronto, ON, M5G 1M1, Canada.
Fasano A; KITE, Toronto Rehabilitation Institute, University Health Network, 550 University Avenue, Toronto, ON, M5G 2A2, Canada.; Division of Neurology, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.; Krembil Brain Institute, Toronto, ON, Canada.; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada.
Gorodetsky C; Division of Neurology, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. .; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada. .
Pokaż więcej
Źródło:
Biomedical engineering online [Biomed Eng Online] 2023 Dec 11; Vol. 22 (1), pp. 120. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Parkinson Disease*/drug therapy
Parkinson Disease*/diagnosis
Subthalamic Nucleus*
Deep Brain Stimulation*/methods
Parkinsonian Disorders*/therapy
Humans ; Aged ; Pilot Projects ; Treatment Outcome ; Gait
Czasopismo naukowe
Tytuł:
Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.
Autorzy:
Taha HB; Department of Integrative Biology & Physiology, University of California Los Angeles, Los Angeles, California, USA.
Ati SS; Department of Integrative Biology & Physiology, University of California Los Angeles, Los Angeles, California, USA.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Dec; Vol. 29 (12), pp. 3741-3755. Date of Electronic Publication: 2023 Jul 07.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Extracellular Vesicles*
Multiple System Atrophy*/diagnosis
Parkinson Disease*/diagnosis
Parkinsonian Disorders*/diagnosis
Humans ; alpha-Synuclein ; Biomarkers ; Central Nervous System
Czasopismo naukowe
Tytuł:
History of Parkinson's Disease-Associated Gene, Parkin : Research over a Quarter Century in Quest of Finding the Physiological Substrate.
Autorzy:
Kitada T; Otawa-Kagaku, Parkinson Clinic and Research, Kamakura 247-0061, Japan.
Ardah MT; Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Haque ME; Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.; Zayed Center for Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 24; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Parkinson Disease*/metabolism
Parkinsonian Disorders*/genetics
Humans ; Ubiquitin-Protein Ligases/genetics ; Ubiquitin-Protein Ligases/metabolism ; Proteins/genetics
Czasopismo naukowe
Tytuł:
Oral Administration of Lactobacillus Inhibits the Permeability of Blood-Brain and Gut Barriers in a Parkinsonism Model.
Autorzy:
Nápoles-Medina AY; Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social, Sierra Mojada #800, Independencia Oriente, C.P. 44340 Guadalajara, Jalisco, Mexico.; Departamento de Farmacobiología, Laboratorio de Microbiología Industrial, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Blvd. Marcelino García Barragán # 1421, Olímpica, C.P. 44430 Guadalajara, Jalisco, Mexico.
Aguilar-Uscanga BR; Departamento de Farmacobiología, Laboratorio de Microbiología Industrial, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Blvd. Marcelino García Barragán # 1421, Olímpica, C.P. 44430 Guadalajara, Jalisco, Mexico.
Solís-Pacheco JR; Departamento de Farmacobiología, Laboratorio de Microbiología Industrial, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Blvd. Marcelino García Barragán # 1421, Olímpica, C.P. 44430 Guadalajara, Jalisco, Mexico.
Tejeda-Martínez AR; Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social, Sierra Mojada #800, Independencia Oriente, C.P. 44340 Guadalajara, Jalisco, Mexico.
Ramírez-Jirano LJ; División de Neurociencias, Centro de Investigación Biomédica Occidente (IMSS), Guadalajara, Mexico.
Urmeneta-Ortiz MF; Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social, Sierra Mojada #800, Independencia Oriente, C.P. 44340 Guadalajara, Jalisco, Mexico.
Chaparro-Huerta V; Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social, Sierra Mojada #800, Independencia Oriente, C.P. 44340 Guadalajara, Jalisco, Mexico.
Flores-Soto ME; Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social, Sierra Mojada #800, Independencia Oriente, C.P. 44340 Guadalajara, Jalisco, Mexico.
Pokaż więcej
Źródło:
Behavioural neurology [Behav Neurol] 2023 Nov 09; Vol. 2023, pp. 6686037. Date of Electronic Publication: 2023 Nov 09 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Lactobacillus*
Parkinsonian Disorders*
Humans ; Blood-Brain Barrier ; Administration, Oral ; Permeability
Czasopismo naukowe
Tytuł:
Clinical Phenotypes of Progressive Supranuclear Palsy-The Differences in Interleukin Patterns.
Autorzy:
Madetko-Alster N; Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland.
Otto-Ślusarczyk D; Department of Biochemistry, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.
Wiercińska-Drapało A; Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, Wolska 37, 01-201 Warsaw, Poland.
Koziorowski D; Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland.
Szlufik S; Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland.
Samborska-Ćwik J; Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland.
Struga M; Department of Biochemistry, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.
Friedman A; Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland.
Alster P; Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 13; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Supranuclear Palsy, Progressive*/diagnosis
Parkinsonian Disorders*/pathology
Humans ; Interleukin-6 ; Phenotype
Czasopismo naukowe
Tytuł:
[Parkinson-dementia and amyotrophic lateral sclerosis association (complex of Guam). Diagnostic challenge, Mexican patient].
Autorzy:
Aguilar-Vázquez CA; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Servicio de Neurología. Ciudad de México, México.
Gallardo-González LI; Petróleos Mexicanos, Hospital Regional PEMEX Poza Rica, Servicio de Medicina Interna. Poza Rica, Veracruz, México.
Raymundo-Carrillo AD; Petróleos Mexicanos, Hospital Regional PEMEX Poza Rica, Servicio de Medicina Interna. Poza Rica, Veracruz, México.
Reyes-Sosa LC; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Servicio de Neurología. Ciudad de México, México.
Martínez-Romo ES; Petróleos Mexicanos, Hospital Regional PEMEX Poza Rica, Servicio de Medicina Interna. Poza Rica, Veracruz, México.
Pokaż więcej
Transliterated Title:
Asociación Parkinson-demencia y esclerosis lateral amiotrófica (complejo Guam). Reto diagnóstico, paciente mexicano.
Źródło:
Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2023 Sep 04; Vol. 61 (5), pp. 677-684. Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Case Reports; English Abstract; Journal Article
MeSH Terms:
Amyotrophic Lateral Sclerosis*/complications
Amyotrophic Lateral Sclerosis*/diagnosis
Amyotrophic Lateral Sclerosis*/epidemiology
Parkinson Disease*/complications
Parkinson Disease*/pathology
Dementia*/complications
Dementia*/epidemiology
Dementia*/pathology
Neurodegenerative Diseases*
Parkinsonian Disorders*/etiology
Parkinsonian Disorders*/complications
Humans ; Guam/epidemiology
Czasopismo naukowe
Tytuł:
Wilson Disease: A Case Report of Psychosis Preceding Parkinsonism.
Autorzy:
Dunkerton S; Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Clarke AJ; Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Thompson EO; Department of Radiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Xie P; Department of Psychiatry, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Tisch S; Department of Neurology, St Vincents Hospital, Sydney, NSW, Australia.; School of Medicine, University of New South Wales, Sydney, NSW, Australia.
Worthington JM; Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Azadi A; Department of Psychiatry, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Halmagyi GM; Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Aug 16; Vol. 24, pp. e940561. Date of Electronic Publication: 2023 Aug 16.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hepatolenticular Degeneration*/complications
Hepatolenticular Degeneration*/diagnosis
Psychotic Disorders*/etiology
Parkinsonian Disorders*/etiology
Parkinsonian Disorders*/complications
Male ; Humans ; Middle Aged ; Copper/metabolism ; Dysarthria/etiology
Czasopismo naukowe
Tytuł:
Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment.
Autorzy:
Cedergren Weber G; Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
Timpka J; Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
Rydelius A; Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
Bengzon J; Division of Neurosurgery, Department of Clinical Sciences, Kamprad laboratory, Lund University, Lund, Sweden.; Department of Neurosurgery, Skåne University Hospital, Lund, Sweden.
Odin P; Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Skåne University Hospital, Lund, Sweden.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2023 Aug; Vol. 13 (8), pp. e3151. Date of Electronic Publication: 2023 Jul 11.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Parkinsonian Disorders*/drug therapy
Parkinsonian Disorders*/complications
Brain Neoplasms*/complications
Brain Neoplasms*/drug therapy
Astrocytoma*/complications
Paraneoplastic Syndromes*/complications
Meningeal Neoplasms*/complications
Cysts*/complications
Humans ; Dopamine
Czasopismo naukowe
Tytuł:
Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
Autorzy:
Sorrell L; University of Plymouth, Plymouth, United Kingdom.
Leta V; Department of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom.; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, United Kingdom.
Barnett A; University of Plymouth, Plymouth, United Kingdom.
Stevens K; Exploristics Ltd, Belfast, Northern Ireland, United Kingdom.
King A; University of Plymouth, Plymouth, United Kingdom.
Inches J; University of Plymouth, Plymouth, United Kingdom.; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
Kobylecki C; Division of Neuroscience and Experimental Psychology, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.; Department of Neurology, Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom.
Walker R; Department of Medicine, North Tyneside Hospital, Northumbria Healthcare NHS Foundation Trust, North Shields, United Kingdom.; Population Health Science Institute, Newcastle University, Newcastle, United Kingdom.
Chaudhuri KR; Department of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom.; Parkinson's Foundation Centre of Excellence, King's College Hospital, London, United Kingdom.
Martin H; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom.
Rideout J; Expert by Experience, London, United Kingdom.
Sneyd JR; Expert by Experience, London, United Kingdom.
Campbell S; University of Plymouth, Plymouth, United Kingdom.
Carroll C; University of Plymouth, Plymouth, United Kingdom.; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.; Newcastle University, Newcastle, United Kingdom.
Pokaż więcej
Corporate Authors:
COVID-19 PD UK study team
Źródło:
PloS one [PLoS One] 2023 Jul 31; Vol. 18 (7), pp. e0285349. Date of Electronic Publication: 2023 Jul 31 (Print Publication: 2023).
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
Parkinson Disease*/complications
Parkinson Disease*/epidemiology
Frailty*
Parkinsonian Disorders*/complications
Parkinsonian Disorders*/epidemiology
Humans ; Male ; Aged, 80 and over ; Female ; SARS-CoV-2 ; Retrospective Studies ; Aftercare ; Patient Discharge ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł:
Manganese-Induced Parkinsonism: Evidence from Epidemiological and Experimental Studies.
Autorzy:
Lucchini R; Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.
Tieu K; Department of Environmental Health Sciences, Florida International University, Miami, FL 33199, USA.; Biomolecular Sciences Institute, Florida International University, Miami, FL 33199, USA.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 Jul 30; Vol. 13 (8). Date of Electronic Publication: 2023 Jul 30.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
Parkinsonian Disorders*/chemically induced
Parkinsonian Disorders*/epidemiology
Parkinson Disease*/epidemiology
Parkinson Disease*/etiology
Humans ; Manganese/toxicity ; Genetic Predisposition to Disease
Czasopismo naukowe
Tytuł:
Parkinsonism as the presenting manifestation of lupus: A case-based review.
Autorzy:
Mv P; Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India.
Maikap D; Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India.
Padhan P; Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Jul; Vol. 32 (8), pp. 1001-1007. Date of Electronic Publication: 2023 Jun 02.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/drug therapy
Lupus Vasculitis, Central Nervous System*/diagnosis
Parkinsonian Disorders*/diagnosis
Parkinsonian Disorders*/drug therapy
Parkinsonian Disorders*/etiology
Humans ; Female ; Middle Aged ; Methylprednisolone
SCR Disease Name:
malar rash
Czasopismo naukowe
Tytuł:
Diagnostic accuracy of F-FP-CIT PET for clinically uncertain Parkinsonian syndrome.
Autorzy:
Oh M; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.
Oh SJ; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.
Lee SJ; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.
Oh JS; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.
Chung SJ; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim JS; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 12; Vol. 13 (1), pp. 15069. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Parkinsonian Disorders*/diagnostic imaging
Parkinson Disease, Secondary*
Humans ; Female ; Male ; Middle Aged ; Aged ; Uncertainty ; Dopamine ; Positron-Emission Tomography
Czasopismo naukowe
Tytuł:
Dopamine Transporter Scan (DAT) in Parkinsonism - a Short Review for Non-Neurologists.
Autorzy:
Gopalakrishnan B; Movement Disorders Center, Butler Hospital, and Department of Neurology, The Warren Alpert Medical School of Brown University, Providence, RI.
Friedman JH; Movement Disorders Center, Butler Hospital, and Department of Neurology, The Warren Alpert Medical School of Brown University, Providence, RI.
Pokaż więcej
Źródło:
Rhode Island medical journal (2013) [R I Med J (2013)] 2023 Sep 01; Vol. 106 (8), pp. 29-30. Date of Electronic Publication: 2023 Sep 01.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Parkinsonian Disorders*/diagnostic imaging
Parkinson Disease*
Humans ; Dopamine Plasma Membrane Transport Proteins ; Radionuclide Imaging
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies